Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.
Immunity. 2024 Mar 12;57(3):587-599.e4. doi: 10.1016/j.immuni.2024.01.017. Epub 2024 Feb 22.
Immunity. 2024.
PMID: 38395697
Free PMC article.
The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera.
Singh G, Abbad A, Kleiner G, Srivastava K, Gleason C; PARIS Study Group; Carreño JM, Simon V, Krammer F.
Singh G, et al.
mBio. 2024 Jan 16;15(1):e0225023. doi: 10.1128/mbio.02250-23. Epub 2023 Dec 19.
mBio. 2024.
PMID: 38112467
Free PMC article.
Item in Clipboard
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
Clark J, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F.
Clark J, et al.
bioRxiv [Preprint]. 2024 Mar 1:2024.02.28.582613. doi: 10.1101/2024.02.28.582613.
bioRxiv. 2024.
PMID: 38464151
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite